Content Moved to its own space:
http://www.ashehata.com/x/BoCmAQ
Robert Malone (linkedin)
...
| title | Robert Malone Experiences - from linked in, pasted below in case it gets removed |
|---|
CEO, Analyst and Consultant: Proposal Development, Clinical Research, Vaccines and BiologicsCEO, Analyst and Consultant: Proposal Development, Clinical Research, Vaccines and Biologics
...
RW Malone MD, LLCRW Malone MD, LLC
RW Malone MD LLC is a customer-focused premier consultancy and analytics group, specializing in analytics for the bio-sector, commercial intelligence, opportunity capture, clinical trials and proposal development.RW Malone MD LLC is a customer-focused premier consultancy and analytics group, specializing in analytics for the bio-sector, commercial intelligence, opportunity capture, clinical trials and proposal development.
CEOCEO
...
Medical Director, VaccinesMedical Director, Vaccines
...
Business development, medical monitoring, proposal management, strategic consulting. This retainer position was contracted under RW Malone MD, LLC.Business development, medical monitoring, proposal management, strategic consulting. This retainer position was contracted under RW Malone MD, LLC.
...
Adjunct Associate ProfessorAdjunct Associate Professor
...
Associate Professor in BiotechnologyAssociate Professor in Biotechnology
Editor in ChiefEditor in Chief
...
Medical Director, VaccinesMedical Director, Vaccines
...
As a member of Accelovance’s Executive Management team, Dr. Malone combines entrepreneurial business talents and biotech industry expertise on a global scale to support the vision of the company. This retainer position was contracted under RW Malone MD, LLCAs a member of Accelovance’s Executive Management team, Dr. Malone combines entrepreneurial business talents and biotech industry expertise on a global scale to support the vision of the company. This retainer position was contracted under RW Malone MD, LLC
...
consultantconsultant
...
Consulting in Alternative delivery technologies, including clinical trials consulting and management in Brazil. This retainer position was contracted under RW Malone MD, LLCConsulting in Alternative delivery technologies, including clinical trials consulting and management in Brazil. This retainer position was contracted under RW Malone MD, LLC
...
Senior Director, Vaccines and TherapeuticsSenior Director, Vaccines and Therapeutics
...
Part time service on retainer focused on product development and transition from pre-clinical to clinical development, Business planning and development, and proposal development.Part time service on retainer focused on product development and transition from pre-clinical to clinical development, Business planning and development, and proposal development.
...
Director, Clinical Development/Medical Affairs, InfluenzaDirector, Clinical Development/Medical Affairs, Influenza
...
Responsibilities included leading an extended clinical team (both internal and CRO components), providing project and clinical trials management oversight, serving as primary author on clinical protocols, strategic documents including clinical development plans, all clinical documents required to support IND filing, generating and managing cost projections and budgetary oversight, providing strategic management and serving as a communication hub for clinical aspects of a 300M USD federal contract to develop and license a cell-based influenza vaccine.Responsibilities included leading an extended clinical team (both internal and CRO components), providing project and clinical trials management oversight, serving as primary author on clinical protocols, strategic documents including clinical development plans, all clinical documents required to support IND filing, generating and managing cost projections and budgetary oversight, providing strategic management and serving as a communication hub for clinical aspects of a 300M USD federal contract to develop and license a cell-based influenza vaccine.
...
Senior Medical DirectorSenior Medical Director
...
Summit is a drug development services provider addressing due diligence assessments and strategic drug development planning to preparing regulatory submissions and implementing, monitoring, and analyzing clinical trials for its clients. While serving at Summit, Dr. Malone was the primary author of three pIND, two IND, an Appendix M submission and has served as proposal manager and primary author for a 129M USD federal contract submission focused on pandemic influenza.Summit is a drug development services provider addressing due diligence assessments and strategic drug development planning to preparing regulatory submissions and implementing, monitoring, and analyzing clinical trials for its clients. While serving at Summit, Dr. Malone was the primary author of three pIND, two IND, an Appendix M submission and has served as proposal manager and primary author for a 129M USD federal contract submission focused on pandemic influenza.
Associate Director, Clinical ResearchAssociate Director, Clinical Research
...
Assistant ProfessorAssistant Professor
...
Assistant Professor , PathologyAssistant Professor , Pathology
...
Research FellowResearch Fellow
...
ScientistScientist
...
Invented naked DNA and RNA delivery, DNA vaccine technologyInvented naked DNA and RNA delivery, DNA vaccine technology
...
Graduate StudentGraduate Student
...
Pioneering work in mRNA structure, function, delivery, non-viral gene deliveryPioneering work in mRNA structure, function, delivery, non-viral gene delivery
...
Foreman, Shingling crewForeman, Shingling crew
...
Leadership of construction crew of 3-4 contractors, assistance with design and implementation of unique private residence located in the Mission Canyon area of Santa Barbara. An on line video clip of the home can be found in the HGTV "Extreme Homes" video library at http://www.hgtv.com/videos/a-whale-of-a-house/3406.html
...
| author | The Center Square |
|---|---|
| url | https://www.thecentersquare.com/indiana/indiana-life-insurance-ceo-says-deaths-are-up-40-among-people-ages-18-64/article_71473b12-6b1e-11ec-8641-5b2c06725e2c.html |
(The Center Square) – The head of Indianapolis-based insurance company OneAmerica said the death rate is up a stunning 40% from pre-pandemic levels among working-age people.
“We are seeing, right now, the highest death rates we have seen in the history of this business – not just at OneAmerica,” the company’s CEO Scott Davison said during an online news conference this week. “The data is consistent across every player in that business.”
OneAmerica is a $100 billion insurance company that has had its headquarters in Indianapolis since 1877. The company has approximately 2,400 employees and sells life insurance, including group life insurance to employers in the state.
Davison said the increase in deaths represents “huge, huge numbers,” and that’s it’s not elderly people who are dying, but “primarily working-age people 18 to 64” who are the employees of companies that have group life insurance plans through OneAmerica.
“And what we saw just in third quarter, we’re seeing it continue into fourth quarter, is that death rates are up 40% over what they were pre-pandemic,” he said.
“Just to give you an idea of how bad that is, a three-sigma or a one-in-200-year catastrophe would be 10% increase over pre-pandemic,” he said. “So 40% is just unheard of.”
Davison was one of several business leaders who spoke during the virtual news conference on Dec. 30 that was organized by the Indiana Chamber of Commerce.
Most of the claims for deaths being filed are not classified as COVID-19 deaths, Davison said.
“What the data is showing to us is that the deaths that are being reported as COVID deaths greatly understate the actual death losses among working-age people from the pandemic. It may not all be COVID on their death certificate, but deaths are up just huge, huge numbers.”
He said at the same time, the company is seeing an “uptick” in disability claims, saying at first it was short-term disability claims, and now the increase is in long-term disability claims.
“For OneAmerica, we expect the costs of this are going to be well over $100 million, and this is our smallest business. So it’s having a huge impact on that,” he said.
He said the costs will be passed on to employers purchasing group life insurance policies, who will have to pay higher premiums.
The CDC weekly death counts, which reflect the information on death certificates and so have a lag of up to eight weeks or longer, show that for the week ending Nov. 6, there were far fewer deaths from COVID-19 in Indiana compared to a year ago – 195 verses 336 – but more deaths from other causes – 1,350 versus 1,319.
These deaths were for people of all ages, however, while the information referenced by Davison was for working-age people who are employees of businesses with group life insurance policies.
At the same news conference where Davison spoke, Brian Tabor, the president of the Indiana Hospital Association, said that hospitals across the state are being flooded with patients “with many different conditions,” saying “unfortunately, the average Hoosiers’ health has declined during the pandemic.”
In a follow-up call, he said he did not have a breakdown showing why so many people in the state are being hospitalized – for what conditions or ailments. But he said the extraordinarily high death rate quoted by Davison matched what hospitals in the state are seeing.
"What it confirmed for me is it bore out what we're seeing on the front end,..." he said.
The number of hospitalizations in the state is now higher than before the COVID-19 vaccine was introduced a year ago, and in fact is higher than it’s been in the past five years, Dr. Lindsay Weaver, Indiana’s chief medical officer, said at a news conference with Gov. Eric Holcomb on Wednesday.
Just 8.9% of ICU beds are available at hospitals in the state, a low for the year, and lower than at any time during the pandemic. But the majority of ICU beds are not taken up by COVID-19 patients – just 37% are, while 54% of the ICU beds are being occupied by people with other illnesses or conditions.
...